Stock-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2023

Stock-Based Compensation

Schedule of stock option activity under all of the Company's equity incentive plans

					Weighted
			Weighted		Average
	Shares	Number of	Average		Remaining	Aggregate
	Available for	Shares	Exercise		Contractual	Intrinsic
	Grant	Outstanding	Price		Life (Years)	Value (000’s)
Available and outstanding as of December 31, 2022	3,538,268	10,081,915	$	3.11	7.61	$	4,098
2022 Plan annual increase	1,917,456	—		—	—		—
Granted	(975,000)	975,000		0.44	—		—
Exercised	—	(451,020)		0.58	—		—
Forfeited	1,200,240	(1,200,240)		4.50	—		—
Available and outstanding as of June 30, 2023	5,680,964	9,405,655	$	2.78	7.45	$	166
Vested and exercisable as of June 30, 2023	—	5,252,184	$	2.27	6.38	$	42

Schedule of assumptions utilized for option grants

	Three-months ended				Six-months ended
	June 30,				June 30,
	2023		2022		2023		2022
Risk-free interest rate	3.62	%	—	%	3.62	%	0.96	%
Expected dividend yield	—	%	—	%	—	%	—	%
Expected volatility	54.73	%	—	%	54.71	%	53.84	%
Expected term (in years)	5.4		—		5.4		6.1

Schedule of stock-based compensation expense recognized in the Company's condensed consolidated statements of operations

	Three-months ended				Six-months ended
	June 30,				June 30,
	2023		2022		2023		2022
Cost of revenue, net	$	107	$	82	$	200	$	162
Research and development		125		243		125		470
Sales and marketing		55		61		108		132
General and administrative		444		341		744		688
Total	$	731	$	727	$	1,177	$	1,452